Page last updated: 2024-12-05

4-mercuribenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5460680
CHEBI ID20435
MeSH IDM0127755

Synonyms (7)

Synonym
CHEBI:20435
4-mercuribenzoate
(4-carboxylatophenyl)mercurate(1-)
p-mercuribenzoate
(4-carboxylatophenyl)mercury
3M1J
Q27109299
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
mercuribenzoate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (12)

PathwayProteinsCompounds
superpathway of 5-aminoimidazole ribonucleotide biosynthesis636
5-aminoimidazole ribonucleotide biosynthesis I1238
5-aminoimidazole ribonucleotide biosynthesis II632
thioredoxin pathway28
L-threonine degradation II331
L-threonine degradation III (to methylglyoxal)328
L-rhamnose degradation II623
L-rhamnose degradation I822
superpathway of fucose and rhamnose degradation1141
aminopropanol phosphate biosynthesis II328
superpathway of L-threonine metabolism2172
trans-4-hydroxy-L-proline degradation II643

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Carbonic anhydrase 2Homo sapiens (human)IC50 (µMol)15.000015.000015.000015.0000AID977608
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2010ChemMedChem, Dec-03, Volume: 5, Issue:12
The x-ray structure of the adduct between NAMI-A and carbonic anhydrase provides insights into the reactivity of this metallodrug with proteins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (47.06)18.7374
1990's5 (29.41)18.2507
2000's1 (5.88)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]